• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Upstream Bio

Upstream Bio is a biotech company aiming to develop therapies that get to the source of inflammation. 

salmon river fish jump upstream katmai alaska
Biotech

Upstream posts phase 2 sinusitis win

Upstream Bio has sailed to a phase 2 win in sinusitis and plans to push its candidate forward against a competitive current.
Nick Paul Taylor Sep 2, 2025 8:00am
The Top Line

What can we learn from 2024’s biotech IPOs?

Dec 6, 2024 8:44am
Photo of Wall Street street sign with american flags in the background

Upstream swells IPO to $255M as it lists alongside CAMP4

Oct 11, 2024 5:18am
IPO initial public offering wall street

CAMP4 is latest to eye IPO, while Upstream spells out $182M plan

Oct 7, 2024 8:44am
salmon river fish jump upstream katmai alaska

Inflammation-focused Upstream to join trickle of biotech IPOs

Sep 19, 2024 4:50am
parachute chutes

Lonza lands new CEO—Chutes & Ladders

Apr 5, 2024 8:30am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings